Literature DB >> 1822436

The outer membrane permeability-increasing action of linear analogues of polymyxin B nonapeptide.

M Vaara1.   

Abstract

Polymyxin nonapeptides such as polymyxin B nonapeptide (PMBN) are polymyxin-derived deacylated nonapeptides which contain a heptapeptide ring and are known as effective permeabilizers of the outer membrane (OM) of Gram-negative bacteria. In order to assess the role of the cyclic moiety of PMBN in the permeabilization of the OM, the author compared the OM permeabilizing activity of two synthetic linear PMBN analogues with the well-characterized activity of PMBN. While a low concentration (1-3 micrograms/ml) of PMBN was sufficient to sensitize both Escherichia coli and Pseudomonas aeruginosa to hydrophobic probe antibiotics (rifampin, fusidic acid) by a factor of 100, even a high concentration (100 micrograms/ml) of linear arginyl polymyxin B decapeptide sensitized E. coli only by a factor of 3 and did not sensitize P. aeruginosa at all. In identical assays, linear lysyl polymyxin B nonapeptide completely lacked any sensitizing activity. These findings indicate that the cyclic peptide ring is crucial for the OM-permeabilizing activity of polymyxin nonapeptides.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1822436

Source DB:  PubMed          Journal:  Drugs Exp Clin Res        ISSN: 0378-6501


  11 in total

Review 1.  Agents that increase the permeability of the outer membrane.

Authors:  M Vaara
Journal:  Microbiol Rev       Date:  1992-09

2.  [Colistin : renaissance of an old antibiotic?].

Authors:  H Stocker; W V Kern
Journal:  Internist (Berl)       Date:  2013-08       Impact factor: 0.743

Review 3.  Structure--activity relationships of polymyxin antibiotics.

Authors:  Tony Velkov; Philip E Thompson; Roger L Nation; Jian Li
Journal:  J Med Chem       Date:  2010-03-11       Impact factor: 7.446

4.  Amyloid beta 42 peptide (Abeta42)-lowering compounds directly bind to Abeta and interfere with amyloid precursor protein (APP) transmembrane dimerization.

Authors:  Luise Richter; Lisa-Marie Munter; Julia Ness; Peter W Hildebrand; Muralidhar Dasari; Stephanie Unterreitmeier; Bruno Bulic; Michael Beyermann; Ronald Gust; Bernd Reif; Sascha Weggen; Dieter Langosch; Gerd Multhaup
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-02       Impact factor: 11.205

Review 5.  Rediscovering the octapeptins.

Authors:  Tony Velkov; Kade D Roberts; Jian Li
Journal:  Nat Prod Rep       Date:  2017-03-17       Impact factor: 13.423

6.  Synthetic bactericidal peptide based on CAP37: a 37-kDa human neutrophil granule-associated cationic antimicrobial protein chemotactic for monocytes.

Authors:  H A Pereira; I Erdem; J Pohl; J K Spitznagel
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-15       Impact factor: 11.205

7.  A Novel Chemical Biology Approach for Mapping of Polymyxin Lipopeptide Antibody Binding Epitopes.

Authors:  Tony Velkov; Bo Yun; Elena K Schneider; Mohammad A K Azad; Olan Dolezal; Faye C Morris; Roger L Nation; Jiping Wang; Ke Chen; Heidi H Yu; Lv Wang; Philip E Thompson; Kade D Roberts; Jian Li
Journal:  ACS Infect Dis       Date:  2016-03-29       Impact factor: 5.084

Review 8.  Pharmacology of polymyxins: new insights into an 'old' class of antibiotics.

Authors:  Tony Velkov; Kade D Roberts; Roger L Nation; Philip E Thompson; Jian Li
Journal:  Future Microbiol       Date:  2013-06       Impact factor: 3.165

Review 9.  Antimicrobial photodynamic therapy to kill Gram-negative bacteria.

Authors:  Felipe F Sperandio; Ying-Ying Huang; Michael R Hamblin
Journal:  Recent Pat Antiinfect Drug Discov       Date:  2013-08

10.  Impact of Intrinsic Resistance Mechanisms on Potency of QPX7728, a New Ultrabroad-Spectrum Beta-Lactamase Inhibitor of Serine and Metallo-Beta-Lactamases in Enterobacteriaceae, Pseudomonas aeruginosa, and Acinetobacter baumannii.

Authors:  Olga Lomovskaya; Kirk Nelson; Debora Rubio-Aparicio; Ruslan Tsivkovski; Dongxu Sun; Michael N Dudley
Journal:  Antimicrob Agents Chemother       Date:  2020-05-21       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.